manilatimes8m
Akeso Announces IND Acceptance for AK139, a Bispecific Antibody Targeting IL-4Rα and ST2 for Respiratory and Skin Diseases
Akeso, Inc. (9926. HK) ('Akeso' or the 'Company') is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Administration (NMPA) ...
Medscape14h
Blood Test Predicts How Long Vaccines Will Protect You
Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...
Le Lézard32m
Akeso Announces IND Acceptance for AK139, a Bispecific Antibody Targeting IL-4R? and ST2 for Respiratory and Skin Diseases
Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Administration (NMPA) ...
Frontiers17h
New Generation Bacterial Vaccines Based on Immune Correlates of Protection
The development of bacterial vaccines has played a critical role in combating infectious diseases, significantly reducing mortality and morbidity worldwide.
emjreviews.com12h
Pseudomonas Infection Triggers Lung Transplant Rejection Through Immune Disruption
Pseudomonas aeruginosa triggers lung transplant rejection by killing regulatory T cells, revealing new targets for AMR ...